EV/EBITDA:
56.22-1.02(-1.78%)Summary
- As of today, TGTX EV/EBITDA is 56.22, with a fall of -1.02 (-1.78%) during the most recent trading session on October 22, 2025.
- Over the past year, TGTX EV/EBITDA has dropped by -563.80 (-90.93%).
- TGTX EV/EBITDA is now -93.77% below its all-time high of 903.07.
Performance
TGTX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TGTX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -1.8% | -1.8% | -1.8% |
| 1M1 Month | -1.1% | -1.1% | -1.1% |
| 3M3 Months | -7.1% | -7.1% | -7.4% |
| 6M6 Months | -33.9% | -8.6% | -8.9% |
| YTDYTD | -39.3% | +18.5% | +14.9% |
| 1Y1 Year | -90.9% | +48.8% | +42.6% |
| 5Y5 Years | +478.1% | +65.2% | +26.1% |
TGTX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 59.86 | -6.1% | 54.87 | +2.5% |
| 3M | 3-Month | 60.86 | -7.6% | 42.90 | +31.1% |
| 6M | 6-Month | 102.00 | -44.9% | 42.90 | +31.1% |
| 1Y | 1-Year | 903.07 | -93.8% | 42.90 | +31.1% |
| 3Y | 3-Year | 903.07 | -93.8% | -72.04 | +178.0% |
| 5Y | 5-Year | 903.07 | -93.8% | -72.04 | +178.0% |
| All-Time | All-Time | 903.07 | -93.8% | -72.04 | +178.0% |
TGTX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 56.22(-39.3%) |
| 2024 | 92.61(-2.5%) |
| 2023 | 95.00(+1324.2%) |
| 2022 | -7.76(-6.7%) |
| 2021 | -7.27(+70.6%) |
| 2020 | -24.76(-262.5%) |
| 2019 | -6.83(-290.3%) |
| 2018 | -1.75(+62.2%) |
| Date | Value |
|---|---|
| 2017 | -4.63(-52.8%) |
| 2016 | -3.03(+67.6%) |
| 2015 | -9.34(+20.7%) |
| 2014 | -11.78(-144.9%) |
| 2013 | -4.81(-48.9%) |
| 2012 | -3.23(-7975.0%) |
| 2011 | -0.04(+99.2%) |
| 2010 | -5.13 |
FAQ
- What is TG Therapeutics, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for TG Therapeutics, Inc.?
- What is TGTX EV/EBITDA year-to-date change?
- What is TG Therapeutics, Inc. EV/EBITDA year-on-year change?
What is TG Therapeutics, Inc. EV/EBITDA?
The current EV/EBITDA of TGTX is 56.22
What is the all-time high EV/EBITDA for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high EV/EBITDA is 903.07
What is TGTX EV/EBITDA year-to-date change?
TG Therapeutics, Inc. EV/EBITDA has changed by -36.39 (-39.29%) since the beginning of the year
What is TG Therapeutics, Inc. EV/EBITDA year-on-year change?
Over the past year, TGTX EV/EBITDA has changed by -563.80 (-90.93%)